About Multiple Sclerosis

Multiple Sclerosis is a chronic, incurable, and unpredictable disease of the central nervous system (the brain, optic nerves, and spinal cord). MS is characterized by the...

Support Our Work (pictured above: Principal Investigators at Tisch MSRCNY)

The Tisch MS Research Center of New York is dedicated to finding the cause of and cure for multiple sclerosis. Tisch MS focuses on translational research, bringing...

Facilities

The Tisch MS Research Center is equipped with the latest in research equipment and technology in order to conduct cutting-edge research for the benefit of people with MS...

Research

At Tisch MS we have several ongoing research projects.  Browse this section to learn more about each project.

FDA Approves Neural Stem Cell Trial

(pictured above Dr. Saud A. Sadiq and Dr. Violaine K. Harris)

Repair Strategies in MS

There are no existing therapies that are capable of repairing the myelin and nerve damage that exist in MS. Dr. Harris and her team focused on adult stem cells from the...

The Tisch MS Research Center of New York is dedicated to finding the cause and cure of multiple sclerosis

Tisch MS News

Last week your Tisch MSRCNY researchers presented six abstracts, including five posters, at the Joint ACTRIMS-ECTRIMS Meeting (Americas and European Committees for Treatment and Research in Multiple Sclerosis) in Boston. This was the sixth triennial event dedicated to advancing the understanding of MS and attracted over 9,000 delegates including more than one hundred exhibitors.

Tisch MS Research Center of New York is proud to be featured in the September 2014 issue of “Neurology Today.” The article “Myelinating Oligodendrocytes Derived from Primary Progressive MS Patients: Scientists Developed Faster, More Efficient Methodology,” discusses research focusing on an accelerated protocol to induce stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system.

Real Time Analytics